(SAP) SAP SE - Overview
Stock: Enterprise Software, Cloud Solutions, Analytics, Business Networks
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.91% |
| Yield on Cost 5y | 2.16% |
| Yield CAGR 5y | 4.70% |
| Payout Consistency | 92.5% |
| Payout Ratio | 35.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 52.6% |
| Relative Tail Risk | -1.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.81 |
| Alpha | -39.23 |
| Character TTM | |
|---|---|
| Beta | 0.863 |
| Beta Downside | 0.722 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.75% |
| CAGR/Max DD | 0.62 |
Description: SAP SAP SE January 26, 2026
SAP SE (NYSE: SAP) delivers a broad suite of enterprise-software solutions, including the S/4HANA ERP platform, SuccessFactors HR suite, Spend Management, Customer Experience, Business Technology Platform, Business Network, Signavio process intelligence, industry-specific applications, and ancillary tools such as LeanIX, WalkMe, Enable Now, Taulia, and sustainability services.
In FY 2023 SAP reported total revenue of €27.84 billion, with cloud-based subscription revenue growing 20 % year-over-year to €9.5 billion, while operating margin held at 21 % despite a modest slowdown in on-premise licensing. R&D intensity remained high at 14 % of revenue, reflecting continued investment in AI-enabled analytics and integration capabilities.
The enterprise-software market is being driven by accelerating digital transformation budgets, a projected 10 % CAGR in global cloud ERP spend through 2028, and heightened demand for AI-augmented process automation. However, macro-economic headwinds-particularly slower corporate capex in Europe and supply-chain volatility-create uncertainty around near-term subscription growth rates.
For a deeper, data-rich assessment of SAP’s valuation dynamics, consider exploring the analyst dashboards on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 7.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 5.81 > 1.0 |
| NWC/Revenue: 8.19% < 20% (prev 6.79%; Δ 1.39% < -1%) |
| CFO/TA 0.13 > 3% & CFO 9.13b > Net Income 7.31b |
| Net Debt (-148.9m) to EBITDA (12.82b): -0.01 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.17b) vs 12m ago -0.34% < -2% |
| Gross Margin: 73.28% > 18% (prev 0.73%; Δ 7255 % > 0.5%) |
| Asset Turnover: 50.82% > 50% (prev 46.11%; Δ 4.72% > 0%) |
| Interest Coverage Ratio: 8.61 > 6 (EBITDA TTM 12.82b / Interest Expense TTM 1.32b) |
Altman Z'' 5.59
| A: 0.04 (Total Current Assets 20.25b - Total Current Liabilities 17.24b) / Total Assets 70.33b |
| B: 0.68 (Retained Earnings 47.49b / Total Assets 70.33b) |
| C: 0.16 (EBIT TTM 11.39b / Avg Total Assets 72.23b) |
| D: 1.95 (Book Value of Equity 48.90b / Total Liabilities 25.11b) |
| Altman-Z'' Score: 5.59 = AAA |
Beneish M -3.08
| DSRI: 0.90 (Receivables 7.27b/7.48b, Revenue 36.71b/34.18b) |
| GMI: 1.00 (GM 73.28% / 72.95%) |
| AQI: 1.00 (AQ_t 0.65 / AQ_t-1 0.65) |
| SGI: 1.07 (Revenue 36.71b / 34.18b) |
| TATA: -0.03 (NI 7.31b - CFO 9.13b) / TA 70.33b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of SAP shares?
Over the past week, the price has changed by +1.53%, over one month by -14.85%, over three months by -16.42% and over the past year by -24.37%.
Is SAP a buy, sell or hold?
- StrongBuy: 7
- Buy: 7
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 305.9 | 45.4% |
| Analysts Target Price | 305.9 | 45.4% |
| ValueRay Target Price | 220.5 | 4.8% |
SAP Fundamental Data Overview February 09, 2026
P/E Forward = 23.1481
P/S = 6.4472
P/B = 4.4842
P/EG = 0.8346
Revenue TTM = 36.71b USD
EBIT TTM = 11.39b USD
EBITDA TTM = 12.82b USD
Long Term Debt = 6.02b USD (from longTermDebt, last quarter)
Short Term Debt = 2.05b USD (from shortTermDebt, last quarter)
Debt = 8.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -148.9m USD (from netDebt column, last quarter)
Enterprise Value = 237.10b USD (237.26b + Debt 8.07b - CCE 8.22b)
Interest Coverage Ratio = 8.61 (Ebit TTM 11.39b / Interest Expense TTM 1.32b)
EV/FCF = 28.24x (Enterprise Value 237.10b / FCF TTM 8.40b)
FCF Yield = 3.54% (FCF TTM 8.40b / Enterprise Value 237.10b)
FCF Margin = 22.87% (FCF TTM 8.40b / Revenue TTM 36.71b)
Net Margin = 19.91% (Net Income TTM 7.31b / Revenue TTM 36.71b)
Gross Margin = 73.28% ((Revenue TTM 36.71b - Cost of Revenue TTM 9.81b) / Revenue TTM)
Gross Margin QoQ = 73.01% (prev 73.50%)
Tobins Q-Ratio = 3.37 (Enterprise Value 237.10b / Total Assets 70.33b)
Interest Expense / Debt = 5.73% (Interest Expense 462.7m / Debt 8.07b)
Taxrate = 31.48% (862.8m / 2.74b)
NOPAT = 7.81b (EBIT 11.39b * (1 - 31.48%))
Current Ratio = 1.17 (Total Current Assets 20.25b / Total Current Liabilities 17.24b)
Debt / Equity = 0.18 (Debt 8.07b / totalStockholderEquity, last quarter 44.73b)
Debt / EBITDA = -0.01 (Net Debt -148.9m / EBITDA 12.82b)
Debt / FCF = -0.02 (Net Debt -148.9m / FCF TTM 8.40b)
Total Stockholder Equity = 44.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.12% (Net Income 7.31b / Total Assets 70.33b)
RoE = 16.43% (Net Income TTM 7.31b / Total Stockholder Equity 44.48b)
RoCE = 22.56% (EBIT 11.39b / Capital Employed (Equity 44.48b + L.T.Debt 6.02b))
RoIC = 17.14% (NOPAT 7.81b / Invested Capital 45.54b)
WACC = 8.92% (E(237.26b)/V(245.32b) * Re(9.09%) + D(8.07b)/V(245.32b) * Rd(5.73%) * (1-Tc(0.31)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.25%
[DCF Debug] Terminal Value 76.10% ; FCFF base≈6.86b ; Y1≈7.45b ; Y5≈9.32b
Fair Price DCF = 117.4 (EV 136.55b - Net Debt -148.9m = Equity 136.70b / Shares 1.16b; r=8.92% [WACC]; 5y FCF grow 9.89% → 2.90% )
EPS Correlation: 71.69 | EPS CAGR: 16.74% | SUE: 1.07 | # QB: 2
Revenue Correlation: 90.91 | Revenue CAGR: 9.73% | SUE: -1.66 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.94 | Chg30d=+0.040 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=8.62 | Chg30d=+0.166 | Revisions Net=+4 | Growth EPS=+17.5% | Growth Revenue=+9.3%
EPS next Year (2027-12-31): EPS=10.14 | Chg30d=-0.073 | Revisions Net=+2 | Growth EPS=+17.6% | Growth Revenue=+13.1%